参考文献/References:
[1] Rege V,Mojiminiyi O,Wilcox H, et al. Comparison of kodak amerlite FT4 and TSH-30 with T4 and TSH as first-line thyroid function tests[J].J Nucl Med,1996,29:1-4.
[2] GoodwinTW,Hershman JM. Hyperthyroidism due to inappropriate production human chorionic honadotropin[J].Clin Obstetrics Gynecol,1997,40(1):32.
[3] Marta SC,Montserrat M,Rocio A, et al. Analytical and clinical evaluation of TSH and thyroid hormones by electrochemiluminescent immunoassays[J].Clin Biochemistry,1999,32(6):395-403.
[4] Spencer CA,Lopresti JS,Nicoloff JT, et al. Multiphasic TSH responses to thyroid hormone administration in man[J].J Clin Endocrinol Metab,1995,80:854-859.
[5] Fraser CG,Petersen PH. Desirable standards for laboratory tests if they are to fulfill medical needs[J].Clin Chem,1993,39:1447-1455.
[6] Rasmussen AK,Hilsted L,Perrild H, et al. Discrepancies between thyrotropin(TSH)measurement by four sensitive immunometric assay[J].Clin Chim Acta,1997,259:117-128.
[7] Spencer CA,Takeuchi M,Kazarosyan M, et al. Current status and performance goals for serum thyrotropin(TSH)assays[J].Clin Chem,1996,42(1):140-145.
[8] Trojan J,Schaaf L,Weis G, et al. Isolation and characterization of different subfractions of human serum thyrotropin(hTSH)[J].Exp Clin Endocrinol, 1994,102:33-37.
[9] Spencer CA,Takeuchi M,Kazarosyn M, et al. Interlaboratory/intermethod differences in functional sensitivity of immunometric assays for thyrotropin(TSH):impact on rehability of measurement of subnormal concentration[J].Clin Chem,1995,41:367-374.
相似文献/References:
[1]惠金子,赵德善.Tg、TgAb及TSH在分化型甲状腺癌术前的预测分析[J].国际放射医学核医学杂志,2015,39(2):110.[doi:10.3760/cma.j.issn.1673-4114.2015.02.002]
Hui Jinzi,Zhao Deshan.The prediction of risk of differentiated thyroid carcinoma with preoperative serum thyroid stimulating hormone, thyrogiobulin and antithyroglobulin antibody[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):110.[doi:10.3760/cma.j.issn.1673-4114.2015.02.002]
[2]李敬彦,蒋宁一.分化型甲状腺癌术后131I清甲治疗方法的相关问题[J].国际放射医学核医学杂志,2014,38(1):42.[doi:10.3760/cma.j.issn 1673-4114.2014.01.009]
Li Jingyan,Jiang Ningyi.Issues related to radioactive iodine ablation in patients with differentiated thyroid carcinoma under-going thyroid surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):42.[doi:10.3760/cma.j.issn 1673-4114.2014.01.009]
[3]孟召伟,谭建.美国甲状腺协会和临床内分泌医师协会2012年甲减诊治指南介绍[J].国际放射医学核医学杂志,2013,37(2):124.[doi:10.3760/cma.j.issn.1673-4114.2013.02.016]
MENG Zhao-wei,TAN Jian.Reading and analysis on management guidelines for hypothyroidism published in 2012 by American Thyroid Association and American Association of Clinical Endocrinologists[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):124.[doi:10.3760/cma.j.issn.1673-4114.2013.02.016]
[4]程维维,王辉.促甲状腺激素受体与甲状腺癌关系的研究进展[J].国际放射医学核医学杂志,2012,36(2):69.[doi:10.3760/cma.j.issn.1673-4114.2012.02.002]
CHENG Wei-wei,WANG Hui.Progress in the relationship of thyroid-stimulating hormone receptor and thyroid carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(2):69.[doi:10.3760/cma.j.issn.1673-4114.2012.02.002]
[5]黄丽娟,陈宁,叶静,等.反义肽核酸对促甲状腺激素受体mRNA表达的影响[J].国际放射医学核医学杂志,2012,36(5):310.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.011]
HUANG Li-juan,CHEN Ning,YE Jing,et al.The effects of antisense peptide nucleic acid on the expression of thyroid stimulating hormone receptor mRNA[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(2):310.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.011]
[6]钟兴祥,郑吉祥,蓝冠章,等.Graves甲亢131I治疗前后血清TRAb动态变化及临床价值[J].国际放射医学核医学杂志,2011,35(2):110.[doi:10.3760/cma.j.issn.1673-4114.2011.02.011]
ZHONG Xing-xiang,ZHENG Ji-xiang,LAN Guan-zhang,et al.Changes of serum TRAb after 131I radiotherapy in patients of Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(2):110.[doi:10.3760/cma.j.issn.1673-4114.2011.02.011]
[7]郭永铁.促甲状腺激素与亚临床性甲状腺功能异常[J].国际放射医学核医学杂志,2008,32(6):351.
GUO Yong-tie.Thyroid stimulating hormone and subclinical thyroid dysfunction[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(2):351.
[8]孟召伟,谭建.重组人促甲状腺激素和促再分化药物在分化型甲状腺癌中的应用[J].国际放射医学核医学杂志,2006,30(6):338.
MENG Zhao-wei,TAN Jian.Application of recombinant human thyrotropin and redifferentiation drugs in differentiated thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(2):338.